This infographic explores a contemporary strategy to decrease the risk of cardiovascular disease and mortality associated with end-stage kidney disease (ESKD). In haemodialysis patients, these outcomes are often linked to the interaction between malnutrition and inflammation. Improving cardiovascular outcomes for patients with ESKD requires an understanding of the mechanisms of inflammation and malnutrition and the role of pro-inflammatory uraemic toxins.
Latest articles
All articles
